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Abstract
In this paper we provide an introduction to the techniques for multi-scale complex biological
systems, from the single bio-molecule to the cell, combining theoretical modeling, experiments,
informatics tools and technologies suitable for biological and biomedical research, which are
becoming increasingly multidisciplinary, multidimensional and information-driven. The most
important concepts on mathematical modeling methodologies and statistical inference, bioinfor-
matics and standards tools to investigate complex biomedical systems are discussed and the
prominent literature useful to both the practitioner and the theoretician are presented.
Introduction
New “omics” technologies applied to molecular genetics
analysis are producing huge amounts of raw data.
Biomedical research laboratories are moving towards
an environment, created through the sharing of
resources, in which heterogeneous and complex health
related data, such as molecular data (e.g. genomics,
proteomics), cellular data (e.g. pathways), tissue data,
population data (e.g. genotyping, SNP, epidemiology),
as well as data generated by large scale analysis (e.g.
Simulation data, Modelling, Systems Biology), are all
taken into account as shown in Figure 1.
The future of biomedical scientific research will be to use
massive computing data-crunching applications, data
grids for distributed storage of large amounts of data and
to develop new approaches to the study of the medical
implications of the genome-enabled medical science.
Microarrays, NMR, mass spectrometry, protein chips, gel
electrophoresis data, Yeast-Two-Hybrid, QTL mapping,
gene silencing, and knockout experiments are all
examples of technologies that capture thousands of
measures, often in single experiments.
In this review we introduce the term Biomedical Complex
System, together with some examples, to characterize the
complexity of current models for biological processes
involved in normal and pathological states that make full
use of the current available high-throughput data and
potential applications are highlighted.
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Complex system application in human diseases
Human diseases result from abnormalities in an
extremely complex system of molecular processes. In
these processes, virtually no molecular entity acts in
isolation and complexity is caused by the vast amount of
dependencies between molecular and phenotype fea-
tures. It is a very intuitive concept to represent such
complex information as networks. The field of network
theory has progressed rapidly over the last years (see [1]
for a review of recent results and references) and not
surprisingly, this representation of complex information
has found its way into medical research [2,3]. It has been
suggested that a systems based approach using network
analysis could offer means to combine disease related
information and to identify the most important factors
for the phenotype of the disease. In particular, it has
been stressed that the combination of genomic, proteo-
mic, metabolomic and environmental factors may
provide insights into pathognomonic mechanisms and
lead to novel therapeutic targets. Post-genomic
approaches have already contributed to the understand-
ing of specific aspects of the disease process and to the
development of diagnostic and prognostic clinical
applications. Cardiovascular obesity, diabetes, autoim-
mune diseases, and neurodegenerative disorders are
some of the disease areas that have benefited from
these types of data. Such diseases are the result of
disturbances at different scales in several molecular
interactions and processes, which contribute to an
increased susceptibility to aging, morbidity and mortal-
ity. For such diseases, a vast amount of data originating
from different sources is typically available, but in
common clinical practice different types of data are
interpreted in isolation. It is therefore poorly understood
how different factors act in synergy to cause a complex
disease phenotype. The patterns of dependencies
between these factors may be effectively reflected in
different, connected networks that associate patients
with clinical and molecular abnormalities as well as
environmental determinants. This process of data
integration will allow to understand better the disease
phenotype and to assign patients to specific disease
subtypes [4,5]. We foresee that complex diseases will
prompt the development of classifiers and kernel-based
approaches for clinical decision support, in which many
genome-wide data sources are combined with physiolo-
gical parameters within the patient domain, making use
of novel modeling methodologies.
A great challenge for contemporary Molecular Medicine
is the modeling, description and ultimately the compre-
hension of the origins of complex and multifactorial
pathologies within a Systems Biology framework. Terms
‘multifactorial’ and ‘polygenic’ express the idea that
multiple genes act in combination with lifestyle and
environmental factors. Inheritance of polygenic traits
and diseases does not fit simple patterns as in a pure
Mendelian case, but there is also a strong environmental
component. Many common traits, such as skin colour,
height, and even intelligence, are inherently multifactor-
ial, and also many common diseases, such as type-2
diabetes, obesity, asthma, cancers, mental retardation
aging related diseases, cardiovascular diseases and
obesity, tend to be multifactorial.
As an example of complex pathology, we can consider
human aging. The ageing process is caused by the
progressive lifetime accumulation of damages to macro-
molecules and cells. The capability of the body to set up
a variety of molecular and cellular strategies to cope with
and neutralize these damages is considered a key feature
of longevity. The aging process can be influenced by
several variables such as lifestyle, environment, genetics
and intrinsic stochasticity. For example, transcriptional
noise measurements in young and old cardiomyocytes
by global mRNA amplification as well as quantification
of mRNA levels in a panel of housekeeping and heart-
specific genes increase in the old age compared to the
young one [6]. The understanding of the aging process
raises the question of stability over time of biological
functions (anthagonistic pleiotropy) and of discrimina-
tion among biological and chronological age. Novel
strategies may help to identify new molecular targets that
can be addressed to prolong the lifespan and to improve
the quality of life during aging.
Psychiatric disorders seem to particularly lend them-
selves for a systems based analysis approach. It is well
known that schizophrenia has a strong genetic com-
pound with concordance rates in monozygotic twins
reaching approximately 50%. This increased risk is
Figure 1
Graphical representation of the main components
for the data modeling of Biomedical Complex
System.
BMC Bioinformatics 2009, 10(Suppl 12):I1 http://www.biomedcentral.com/1471-2105/10/S12/I1
Page 2 of 13
(page number not for citation purposes)
conferred by a multitude of different genes with the most
important genetic polymorphisms accounting for 1% of
increased risk. It seems likely that the disease is
ultimately precipitated by a complex interplay of genetic
predisposition and of a broad spectrum of environ-
mental and nutritional factors (see [3] for updated
references on schizophrenia and its identification as a
complex network disease). In this context, epidemiolo-
gical factors such as urbanicity, geographical distribu-
tion, and migration behaviour, but also maternal risk
factors (such as infections, malnutrition, adverse life
events during pregnancy or season of birth), have been
suggested to be associated with the risk of schizophrenia
onset. The relationship between these factors and the
interplay with genetic determinants remains unknown,
and integrated, system based investigations seem to be a
promising approach to obtain deeper insights into the
disease aetiology.
Metabolic syndrome is a combination of medical
disorders that increase the risk of developing athero-
sclerosis, cardiovascular diseases, diabetes and other
pathologies. It affects a significant part of population in
western countries, and its prevalence increases with age.
The exact patho-physiological mechanisms of metabolic
syndrome are not yet completely elucidated, due to the
number of involved factors, and to their interaction
complexity. The most important factors are: weight,
genetics, aging, and lifestyle, i.e., low physical activity
and excess caloric intake. There is debate regarding
whether obesity or insulin resistance (IR, i.e. the condi-
tion in which normal amounts of insulin are inadequate
to produce a normal insulin response) are the cause of the
metabolic syndrome or if they are consequences of amore
far-reaching metabolic derangement. A number of mar-
kers of systemic inflammation, including C-reactive
protein, are often increased, as are fibrinogen, interleukin
6 (IL-6), Tumor necrosis factor-alpha (TNFa) and others.
Some have pointed to a variety of causes including
increased uric acid levels caused by dietary fructose. In
vivo and in vitro studies of insulin signalling network
have provided insights into how insulin resistance can
develop in some pathways, whereas insulin sensitivity is
maintained in others. In a Systems Biology perspective,
this phenomenon can be modelled as a form of
adaptation with consequent switch between stable
phenotypes. This model is supported by experimental
observations showing that the pathways leading to IR
contain several phosphorylation steps, and this can be
sufficient to support multistability and switching among
phenotypes [7].
An emerging field of Medicine is the so called Ecological
Medicine, that is trying to define the health state in terms
of biological community abundance, composition and
type. Recent studies on gut microbiota (the intestinal
bacteria heterogeneous population) show that its com-
position may change with pathological state and ageing.
Since it is also modulated by the Immune System, it can
be seen as a crucial node for determining the interactions
between environment (food) and internal machinery
(Immune and Metabolic system), especially for those
pathologies related to both factors (see for example [8]).
Multidisciplinary complex system theory
A number of physico-mathematical theories are dealing
with systems characterized by a high number of degrees
of freedom, non linear relations between parameters,
high variability and stochastic behaviour. The science of
Complex Biological Systems (ranging from Biochemis-
try, Physics, Biology, Medicine to Social Sciences) is
trying to understand global behaviour and “emergent
properties” (such as self-organization, robustness, for-
mation of memory patterns, etc...) on the basis of
microscopic factors like interacting molecules, com-
plexes, organelles or whole cells, depending on the
scale of the system under study. The unifying framework
is that biological systems are constituted by a very high
number of mutually interacting elements, that organize
themselves in functional and dynamic networks, at
different levels of complexity. The fundamental unit of
living organisms is the cell (that constitutes a complex
system in itself) representing the building block of
higher levels of organization, such as tissues, organs and
whole organisms. Different organisms organize them-
selves in societies and ecological systems, in which
hundreds or even thousands of different species coexist
in a dynamic equilibrium. The evolutionary history of
biological systems, but also the history of single
organisms, entails a series of constraints that can
influence their structure and functional capacities: the
role of evolution and environment can thus provide
useful information about how to treat a specific problem
(e.g. disease). Whereas a thermodynamic approach (in
the limit of system elements going to infinity) is suitable
for complex systems. Thus, the role of stochastic
fluctuations has recently received a renewed interest,
since the focus has moved to mesoscopic scales in which
the number of interacting elements is quite small, the
noise features are not so trivial (i.e. gaussian) and can
drive the system towards unexpected behaviour [9,10].
Recent studies [11-13] based on fluorescence measure-
ments onto the genome of simple bacteria (like E. coli)
have showed that biological noise can be classified as
intrinsic and extrinsic noise. Extrinsic fluctuations are
those that affect equally gene expression in a given cell,
such as variations in the number of RNA polymerases or
ribosomes, that can make cell activity diverge in an
initially uniform population. Intrinsic fluctuations are
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instead those due to the randomness inherent to
transcription and translation; they should affect inde-
pendently each element of the same network (e.g. gene
or protein levels in the same cell) adding uncorrelated
variations in the overall levels of cellular activity. A
deeper understanding of the role of such noises could
help in explaining the different responses of organisms
to the same stressogen and pathologic input.
Measuring and data analysis
The inherent complexity of biological systems requires
suitable experimental, statistical, and computational
strategies: generally speaking, biological experiments
show fundamental differences from physical experi-
ments, such as a higher and non-trivial (non-gaussian)
variability, a lower number of available measurements
(such as the number of points in a kinetic experiment, or
simply the number of experimental repetitions) and the
lack or poor availability of small-scale (single-molecule)
experiments. During the last decade a large class of in
vivo and in vitro measurements has been developed and/
or improved to fill this gap, such as Quantitative mass-
spectrometry, high throughput sequencing, proteomics,
genomics, metabolomics, measurements. Imaging tech-
niques, such as microscopy, ultrasound, CT (Computed
Tomography), MRI (Magnetic Resonance Imaging), PET
(Positron Emission Tomography), using molecular
probes, such as quantum dots and nanoshells, are
capable to produce quantitative and model-confirmatory
data in a wide range of spatial and temporal intervals,
from cells to organs or individuals, and from micro-
seconds to hours. A central feature of all these imaging
techniques is the ability to produce “in vivo” molecular
data in a dynamic way (see [14] for a review).
A common denominator of these methodologies is the
need for powerful computational analysis and sophisti-
cated statistical elaboration. As an example, the high-
throughput gene expression experiments (microarrays)
have posed new classes of statistical problems, due to the
huge number of statistical tests to be performed
simultaneously over widely heterogeneous data, for
which an accurate control of false positive/negative rate
is a crucial issue. The solution of this problem has been
faced in several ways, for example by developing post-
hoc correction methods for the significance threshold
[15,16], or by including “a priori” biological informa-
tion. The observation that gene expression measure-
ments follow a highly skewed and fat-tailed has raised
the question of reconstructing the underlying network of
interactions able to describe such observations [17,18].
Significance analysis at single gene level may suffer from
the limited number of samples and high experimental
noise, that can severely limit the power of the chosen
statistical test. This problem is typically approached by
applying generalized null models [19] to control the
false discovery rate, or taking into account prior
biological knowledge. Pathway or gene ontology analy-
sis can provide an alternative way to enforce single-gene
statistical significance, with the advantage of suggesting a
clearer biological interpretation. The use of “a priori
biological knowledge”, as coded in pathways or ontol-
ogies, may help to detect relationships at multiple scales,
grouping single gene analyses into clusters (pathways,
ontologies) and super-clusters (networks of pathways,
higher-order ontologies) with precise biological func-
tions.
Among different approaches that have been proposed to
identify significant gene groups, a large number is based
on lists of differentially expressed genes such as GOstat
[20] that compares the occurrences of each GO (Gene
Ontology) term in a given list of genes with its
occurrence in a reference group on the array. In the
context of pathway analysis, a similar approach is used
by Pathway Miner [21], which ranks pathways by means
of a one-sided Fisher exact test. Other methods allow
investigators the possibility to define their own gene-
grouping schemes. For example, the Global Test package
[22] applies a generalized linear model to determine if a
user-defined group of genes is significantly related to a
clinical outcome. With the Gene Set Enrichment Analysis
(GSEA [23]) an investigator can test if the members of a
defined gene set tend to occur towards the top or the
bottom of a ranked significance list obtained from
differential expression analysis. Other methods combine
pathway information with Fisher exact test for 2 by 2
contingency tables and its variations [24] allowing
dimensionality reduction of the problem (from 104
probes to 102 pathways) and increasing biological
interpretability of the studied processes. By these
methods, it is possible to consider the single-gene
relevance at different levels of biological organization:
groups of genes as provided by several ontology classes,
pathways and metapathways. The further direction is to
integrate different kinds of biological knowledge (pro-
tein-protein interaction, transcription factor network,
biochemical reaction network, as well as clinical and
aetiological information about the samples) into a
unified framework.
From high throughput data to modelling
Nowadays, an important area of investigation focuses on
using statistical inference for mechanistic models of
partially observed dynamic systems. This area represents
the challenge task of combining statistical methods with
models of dynamical systems. Dynamic models, usually
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written in forms of differential equations (DEs), describe
the rate of change of a process. They are widely used in
medicine, engineering, ecology and a host of other
applications. One central and difficult problem is how to
estimate DE parameters from noisy data. Direct
approaches (such as least squares) give rise to difficulties
partly because of the intrinsic definition of the mathe-
matical model. A formal approach in specify uncertainty
in systems of differential equations within a statistical
inferential framework is something that mathematicians
have only very recently started to consider. There is a
great motivation, within the area of Computational
Systems Biology, to fully define and propagate all
sources of uncertainty in model-based reasoning, with
reference to the genetic, biochemical and cellular
mechanisms initiating and regulating fundamental
biological processes. These systems are non-linear, non-
steady state, and contain many unknown parameters.
A single nonlinear differential equation model can
describe a wide variety of behaviours including oscilla-
tions, steady states and exponential growth and decay,
with relatively few parameters. Noteworthy, many DEs
do not have an analytic solution, implying that a
likelihood centred on the solution to the DE is full of
local maxima, ridges, ripples, flat sections, and other
difficult topologies. If only parts of a genetic, biochem-
ical and cellular network can be observed directly,
structural non-identifiability may then arise and man-
ifests itself in functionally related model parameters
which cannot be estimated uniquely. The challenge in
implementing robust predictive analyses is that integrals
over high-dimensional parameter spaces are usually
involved that can neither be evaluated analytically, nor
numerically in a straight-forward way. Although infer-
ence techniques, such as Maximum Likelihood, are
relatively easy to implement, they suffer from drawbacks,
such as not fully exploring the entire parameter space. As
a solution to this problem, the generalized profiling
method [25] was proposed, in which DE solutions are
approximated by nonparametric functions, which are
estimated by penalized smoothing with DE-defined
penalty. The existing inference methods have substantial
limitations upon the form of models that can be fitted
and, hence, upon the nature of the scientific hypotheses
that can be made and the data that can be used to
evaluate them. Instead, the so called plug-and-play
methods require only simulations from a model and
are thus free from such restrictions. Plug-and-play
inference is extremely useful when one wishes to
entertain multiple working hypotheses translated into
multiple mechanistic models [26]. The Bayesian meth-
odology provides one such inferential framework,
however, whilst beautifully elegant in principle, com-
putational challenges associated with its practical
instantiation are formidable [27], due to a combination
of non-linear non-steady state differential equations
containing many parameters in conjunction with a
limited amount of data. Some currently useful computa-
tional tools are: Laplace’s method of asymptotic approx-
imation and Markov Chain Monte Carlo (MCMC)
methods, including multi-level Metropolis-Hastings
algorithms with tempering, the Gibbs sampler and the
Hybrid Monte Carlo algorithm. Particle filter algorithms
are useful for sequential Bayesian state estimation when
the Kalman filter is not applicable because of non-linear
dynamics and/or non-Gaussian probability models.
Methodologies for modelling technique
What does modelling a complex system mean? From a
strictly physico-mathematical point of view, it means
reproducing the main features of a real system (like
phase transitions and bifurcations, parametric and
stochastic resonance phenomena) by means of a model
with as few parameters as possible, in order to get a
completely controllable system, that can possibly be
treated analytically. Usually, the aim is to learn as much
as possible from such a simplified problem, with the
hope that the original system can be seen as a “small
perturbation” of that (i.e. we are hoping to have caught
the peculiar features). For a complex system, it is
expected that the number of parameters and basilar
elements is not too little, since, very often, the level of
complexity is given by a high number of agents
(composing the system) that are interacting in a non-
trivial way, so that a “mean field” approach is not
suitable. The search for such simplified models is,
without any doubt, very useful, especially from a
theoretical biology point of view, but it may not be the
case for an applied biomedical problem. First, the
essential ingredient of simplification, that is passing
from the specific case to the more general one, is to
discard as many details as possible. But in a biomedical
problem we can be more interested in a particular
solution of our problem, that deals with as many details
as possible of the system (e.g. the features of a specific
pathway involved, or the past history of the sample). The
multiplicity of subclasses in which the parameter space
associated to our system can be divided is the goal of our
modelling, rather than something to “average out” as in
a classical thermodynamic approach to a physical
system. Similarly, we might be more interested in a
multiparametric model that, even if analytically untract-
able, can be repeatedly simulated and “tuned” to a real
situation, rather than in an idealized toy model that has
lost any relationship with reality. Examples that go in
this directions are the so called flux balance analysis
(FBA) or flux optimization, in which the parameters (e.g.
reaction rates) of a real system are changed in order to
study how the reaction yields are affected [28-30]. In this
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sense, the paths to complex system modelling, from a
theoretical and a more applied point of view, may run
together in the beginning, but they may possibly divide
along the road and take different directions. The tradeoff
between the search for a model as simple as possible and
an adequate description of the original complex system
is more markedly present in the fields of biology and
medicine (rather than in physics), because a beautiful
theoretical model may be of no help if it cannot be
brought back to reality. One practical task of modelling
may be to help in the generalization of the results
obtained from simpler organisms (that can be massively
tested by experiments) to humans, by following the
analogies connecting them. This actually is a common
practice for inferring protein functions and interactions
by looking at their (structural) similarities with proteins
from simpler (and more studied) organisms. Thus,
related to this task, deepening the knowledge about
such analogies and their limits is of fundamental
importance for fruitful biomedical achievements. This
can be pursued by cleverly scanning databases, reposi-
tories and ontologies in search for common modules
and structures, and a good modelling must provide hints
and tools for adequate simulations of these different
complex systems (e.g. in their dynamics of response to
stimuli [31,32]).
A classical case study in biophysics is the induction and
maintenance of memory in biological systems (from
small genetic circuits to whole cells as neurons). The
mathematical formulation of this problem is related to
the concept of bistability, both in a deterministic and in a
stochastic formulation. Deterministic bistability is typi-
cally governed by feed-back, auto-catalysis and non linear
interactions, and can be appreciated by stability and
robustness analysis. Stochastic bistability is more subtle,
crucially related to noise level as well as to the real size of
the systems (e.g. the number of proteins participating in a
reaction). An approach that has received renewed atten-
tion, is based on the so called Chemical Master Equation
(CME) that describes the temporal evolution of the
probability of having a given number of molecules for
each chemical species involved. The discrete probabilistic
approach, as with CME, is attractive because it ensures the
correct physical interpretation of fluctuations in the
presence of a small number of reacting elements (as
compared to continuum approaches as Langevin and
Fokker-Planck formalism [33]) and because it provides an
unitary formulation for many biological processes, from
chemical reactions to ion channel kinetics. The CME
theory can be related to predictions on the noise levels in
selected biological processes, as for example during
transcription and translation [34,8]. In particular, the
observation that mRNA is produced in bursts varying in
size and time has led to the development of new models
capable of better explaining the distributions of synthe-
sized products [35].
Computing and standards for large scale
simulation
Due to large data sets and accompanied large number of
parameters being produced by high throughput techni-
ques such as next-generation sequencing able to accel-
erate the entire process from sample preparation to data
analysis, there is a growing usage of high performance
computers based on clustering technologies and high
performance distributed platforms. A first approach to
scalable computer infrastructure has been the use of
large supercomputer cluster following by the introduc-
tion of the grid computing; a more recent one is the
cloud computing. Grid infrastructures are based on a
distributed computing model where easy access to large
geographical computing and data management resources
is provided to large multidisciplinary Virtual Organiza-
tions (VOs). The distributed High Performance Compu-
ter (HPC) is considered the way to realize the concept of
virtual places where scientists and researchers work
together to solve complex problems, despite their
geographic and organizational boundaries. Cloud com-
puting is defined and characterized by massive scal-
ability and Internet-driven economics realised as a pool
of virtualized computer resources. A Cloud Computing
platform supports redundant, self-recovering, highly
scalable programming models that allow workloads to
recover from many unavoidable hardware/software fail-
ures, as well as to monitor resources use in real time for
providing physical and virtual servers on which the
applications can run. In a Cloud Computing platform
software is migrating from the desktop into the “clouds”
of the Internet, promising users anytime, anywhere
access to their software and data.
Characteristics of biological data sources
A huge amount of biological and medical information is
now publicly available. Emerging knowledge domains,
tightly linked to systems biology, like interaction net-
works and metabolic pathways, are contributing with
even huge amounts of data. Information in secondary
databases represents an essential resource for researchers
since they target special research interests. Many data-
banks are created and maintained by small groups or
even by single researchers. As a result of this diffused and
uncoordinated development, data is spread over hun-
dreds of Internet sites and included in a high number of
heterogeneous databases, the majority of which are of a
great interest for systems biology, where it is stored using
different database management systems and data struc-
tures. There are little common information sets and the
semantics of data, i.e. the actual meaning associated to
BMC Bioinformatics 2009, 10(Suppl 12):I1 http://www.biomedcentral.com/1471-2105/10/S12/I1
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each piece of data, is left to the developers. It can
therefore be different, even when using same or similar
names, thus leading to potential confusion. User
interfaces and query methods are also different and
searching, retrieving and integrating information may
become very difficult.
Data integration
One of the main issues in systems biology data
management is data integration in order to represent
the global view of biological information. The data
management involves retrieval of information from
multiple databases and the execution of large scale
data analysis. Data integration can be best achieved
when the information and desired analysis are stable in
time and based on standardization of data models and
formats. In biology the domain’s knowledge changes
very quickly and the complexity of information makes it
difficult to design complex data models. Integrating
biological information in a distributed, heterogeneous
environment requires expandable and adaptable tech-
nologies and tools that are able, at the same time, to
cope with the heterogeneity of data sources and to select
and manage properly the right information, i.e. by
recognizing its semantics.
Among current Information and Communication Tech-
nologies (ICT), the eXtensible Markup Language (XML)
[36] together with XML based biologically oriented
languages, and Semantic tools, like ontologies, are
the most interesting ones in view of the achievement
of a standardized environment for systems biology.
A Markup Language (ML) is a mechanism aimed at
defining parts of a document (i.e. data) by surrounding
it with a start and an end tag. XML specification defines a
way to add markup (tags) to documents and thus assign
meanings to data explicitly. A set of tags and their
relationships defines an XML language and constitutes a
namespace, the context where those tags are valid. XML
languages are defined by using Document Type Defini-
tions (DTDs) or XML Schemas [37].
Many XML languages have been created for biology,
more than can be reviewed here. For the reasons of their
adoption and a short list, see [38-40]. They range from
the basic one, e.g. for the storage of databanks informa-
tion in alternative formats that can improve traditional
flat-file management, and for the description and
archiving of results of main analysis tools, to the most
complex, like those used in specialized knowledge
domains (e.g., the Polymorphism Markup Language
(PML) [41] that has been developed as a common data
exchange format to overcome the heterogeneity of SNPs
databases.
XML languages can also support data interchange. In
order to simplify interoperation between bioinformatics
tools, the HOBIT XML schemas, that refers to some
bioinformatics data types (sequence, RNA structure and
alignment), and the BioDOM software library for their
management were developed [42].
An ontology is the “specification of conceptualization”
in a given domain of interest. It consists of a set of
concepts in that specific domain, expressed by using a
controlled vocabulary, and of the relationships among
these concepts. Ontologies can add semantic metadata to
the resources, improve data accessibility and support
integrated searches. Many biomedical ontologies have
been, or are being, developed, mainly in the context of
the Open Biomedical Ontologies (OBO) initiative [43].
Standards for systems biology
Many reviews have already been published on standar-
dization of data and tools in support of systems biology
development and research. We here refer to them, due to
their completeness and authoritativeness.
Brazma et al published an accurate review in 2006 [44].
They pointed out the main objectives of standardization
in life sciences, gave a classification of existing standards
and produced extended and accurate lists of acronyms,
definitions, URLs. Their classification is based on a table
where rows represent three areas of systems biology
(biological knowledge, evidence produced by technolo-
gies, general frameworks), and columns represent the
four steps of standardization that they define in the
review, namely informal semantics, formal semantics,
formal syntax and tools.
Strömbäck et al [45] and Wierling et al [46] published
reviews where the focus was posed on tools, data standards,
the role of XML languages for data exchange and how
ontologies are used to develop new formats, thus constitut-
ing an essential component of standardization.
The Systems Biology Markup Language (SBML) [47,48]
is defined as “a computer-readable format for represent-
ing models of biochemical reaction networks”. The same
objectives are driving the development of the Cell
System Markup Language (CSML) [49] with the aimed
to visualizing, modelling and simulating biopathways.
The most used data standards are summarize in Table 1.
Database supporting systems biology research
Systems biology research depends on availability of well
structured data sources. Moreover, data is rarely inte-
grated in databases that alone can support research in
even the smallest biological domains. Eils et al suggest
BMC Bioinformatics 2009, 10(Suppl 12):I1 http://www.biomedcentral.com/1471-2105/10/S12/I1
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an “integrative database for systems biology”, defined as
a “data warehouse system” supporting all activities of a
systems biology project [50]. The system would consist
of three modules, one for each of the main involved data
subsets: i) experimental data, ii) components and
reactions of biological systems, and iii) mathematical
models. Both functional models and simulations are
stored by using the SBML format, thus emphasizing the
role and the relevance of standardization in this field.
Many databases are relevant for systems biology and amore
extended list with emphasis on databases on models and
pathways is presented in Table 2. It is implicit that most of
the primary databases, from gene and protein interaction,
are also of interest for systems biology.
BioModels is a database of annotated computational
models [51], manually curated at the European Bioin-
formatics Institute (EBI) as part of the broader BioMo-
dels.net initiative [52]. The BioCyc Database Collection
[53] is a collection of Pathway/Genome Databases,
either derived from literature or computed, including
more than 500 species, mainly bacteria, but also
including homo sapiens and mus musculus. MetaCyc is
instead a database of non-redundant, experimentally
elucidated, metabolic pathways [54].
A methodology for the development of new tools for
systems biology
The following methodology for the development of new
tools for systems biology is meant to implement ways for
sharing data models and definitions based on common
data interchange formats [55]:
• XML schemas can be used for the creation of common
models of biological information,
• XML based languages can be adopted for data storage,
representation and exchange,
• Web Services can be made available for the interoper-
ability of software,
• ontologies can semantically support Web Services
discovery, selection and interoperation,
• Workflow Management Systems can then be used to
implement automated processes.
Although this methodology can be seen very difficult to
be implemented, the Microarray Gene Expression Data
Group (MGED) [56] initiative, lead along the above
lines, can instead be seen as a success story. MGED is an
international society of biologists, computer scientists,
and data analysts that aim to facilitate the sharing of
microarray data. This initiative was devoted to the
creation of a common data structure for communicating
microarray based gene-expression (MAGE) data. This
activity started by defining the Minimum Information
About a Microarray Experiment (MIAME) data set.
MIAME describes the data that is needed to interpret
unambiguously results of any experiment and
Table 1: Standards for systems biology, grouped by type
Minimum Information (see also the MIBBI initiative [58])
MIAME Microarray Experiment http://www.mged.org/Workgroups/MIAME/miame_2.0.html
MIAPE Proteomics Experiment http://www.psidev.info/
MIRIAM Annotation of biochemical Models http://biomodels.net/miriam/
MIACA Cellular Assay (MIACA) http://miaca.sourceforge.net/
Ontologies (see also the OBO Foundry [43])
GO Gene Ontology http://www.geneontology.org/
MO Microarray Ontology http://mged.sourceforge.net/ontologies/MGEDontology.php
PW Pathway ontology http://rgd.mcw.edu/tools/ontology/ont_search.cgi
PSI-MI Protein-protein interaction http://www.psidev.info/
SBO Systems Biology http://www.ebi.ac.uk/sbo/
FuGO Functional Genomics Investigation http://fugo.sourceforge.net/ontologyInfo/ontology.php
XML Languages
MAGE-ML Microarray Gene Expression ML http://www.mged.org/Workgroups/MAGE/mage-ml.html
HUP-ML Human Proteome ML http://www1.biz.biglobe.ne.jp/~jhupo/HUP-ML/hup-ml.html
mzXML Mass spectrometry data ML http://sashimi.sourceforge.net/software.html
SBML Systems Biology ML http://www.sbml.org/Documents/
CSML Cell System ML http://csml.org/
CellML Cell ML http://www.cellml.org/about/about
BioPAX Biological Pathways Exchange http://www.biopax.org/
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potentially reproduce it [57]. MIAME includes raw and
normalised data for each hybridisation in the study,
annotations of the sample and of the array, and other
related information. In order to improve specification of
MIAME information, and therefore its accessibility, a
data exchange model (MAGE-OM) and related data
formats were then defined. Formats are specified as
spreadsheets (MAGE-TAB) and as an XML language
(MAGE-ML). In addition, the MGED Ontology was
developed for the description of key concepts. A software
toolkit (MAGE-STK) was finally developed to facilitate
the adoption of MAGE-OM and MAGE-ML.
Along these lines, many ‘Minimum Information’ datasets
have been defined in other biological domains. Cur-
rently, the Minimum Information for Biological and
Biomedical Investigations (MIBBI) initiative lists some
30 such specifications [58]. This is an extremely good
starting point towards a widespread adoption of above
methodology.
Methodology for the description of complex
biochemical systems
In the last decade, different computing paradigms and
modelling frameworks for the description and simulation
of biochemical systems have been introduce to describe
the complex biological system. Usually the parameter
values are generally unknown or uncertain due to the lack
of measurements, experimental errors and biological
variability and this is a great problem in the development
of cellular models [59]. In the following paragraph we
Table 2: Some of the most interesting databases for systems biology
KEGG Kyoto Encyclopedia of Genes and Genomes
Incudes data on genes and proteins, endogenous and exogenous ligands, diagrams
of interaction and reaction networks, and hierarchies and relationships of various
biological objects
http://www.genome.ad.jp/kegg/
BRENDA The Comprehensive Enzyme Information System
Information on enzymes and their function
http://www.brenda-enzymes.org/
BioCyc Collection of Pathway/Genome Databases
Derived from literature (EcoCyc, MetaCyc) or computed (some 500 databases,
maìnly for bacteria, but also incl. HumanCyc and MouseCyc, about 20 of which are
partially corrected by volunteers)
http://biocyc.org/
CSNdb Cell Signaling Networks Database
Information on molecules, sequences, structures, functions, and reactions
transferring cellular signals in human cells
http://geo.nihs.go.jp/csndb/
BioBase Many commercial databases offered on-line with reduced functionalities
Includes TRANSFAC (transcription factors and their binding sites and regulated
genes) and TRANSPATH (molecules involved in signal transduction pathways and
related reactions)
http://www.gene-regulation.com/pub/databases.html
BioModels A Database of Annotated Published Models
Includes mathematical models published in literature. Models are annotated and
linked to esternal databases and to literature.
http://www.ebi.ac.uk/biomodels-main/
BioUML BioUML is framework for systems biology.
It spans the comprehensive range of capabilities including access to databases with
experimental data, tools for formalized description of biological systems structure
and functioning, as well as tools for their visualization and simulations.
http://www.biouml.org/
CCDB The CCDB is a cell cycle database
Is an integrated data warehouse database for systems biology modelling and cell
cycle analysis
http://www.itb.cnr.it/cellcycle
PID The Pathway Interaction Database
A curated database of biomolecular interactions and key cellular processes
assembled into signaling pathways focused on human data. Human pathways from
Reactome are also included. PID is a collaboration between the NCI and Nature
Publishing Group.
http://pid.nci.nih.gov/PID/
Reactome A curated knowledgebase of biological pathways Information is authored by
experts and curated by internal staff. It includes links to external data sources, like
KEGG Compound, ChEBI, PubMed, and GO.
http://www.reactome.org/
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introduce some of the most important methodologies
used to describe the complex biochemical systems:
• Nonlinear Ordinary differential equations (ODE)
Nonlinear ordinary differential equations represent an
important approach used to describe cellular dynamical
properties when it is possible to consider component
diffusions instantaneous and concentrations sufficiently
high [60]. Considering the cell cycle, ODEs are widely
used to describe the dynamics of its regulations and all
the related published models are stored in the Cell Cycle
Database [61]. Moreover, a specific set of parameters
values describe a model in a particular physiological
state and in a peculiar species. The core regulation of the
cell cycle is widely conserved across different species but
time scales can vary from minutes to hours and the key
elements interactions involved in processes typically vary
across species [62].
• Membrane system (P system)
Membrane systems, also known as P systems have been
introduced in [63], are computation models as a class of
unconventional computing devices of distributed, par-
allel and nondeterministic type, inspired by the com-
partmental structure and the functioning of living cells.
In order to define a basic P system, three main parts need
to be introduced: the membrane structure, the objects
and the rules. For a complete and extensive overview of P
systems, we refer the reader to [64] and to the P Systems
Web Page http://ppage.psystems.eu.
• Tissue system (tP system)
tP systems have been introduce to describe a tissue like
architecture, where cells are placed in the nodes of a
directed graph, and objects are communicated along the
edges of the graph. These communication channels are
called synapses. Moreover, the communication of
objects is achieved both in a replicative and non-
replicative manner, that is, the objects are sent to all
the adjacent cells or to only one adjacent cell, respec-
tively. The variants of tP systems considered in the
literature essentially differ in the mechanisms used to
communicate objects between cells. [64,65].
• Stochastic simulation technique (τ-DD system)
The definition of the stochastic simulation technique
called τ-DD [66], where the probabilities are associated
to the rules, following the method introduced by
Gillespie in [67]. The aim of τ-DD is to extend the
single-volume algorithm of tau-leaping [68], in order to
simulate multi-volume systems, where the distinct
volumes are arranged according to a specified hierarchy.
The τ-DD approach is designed to share a common time
increment among all the membranes, used to accurately
extract the rules that will be executed in each compart-
ment (at each step). This improvement is achieved using,
inside the membranes of τ-DD, a modified tau-leaping
algorithm, which gives the possibility to simulate the
time evolution of every volume as well as that of the
entire system.
Conclusion
In this paper we reviewed some of principal concepts
that, in our opinion, will characterize the next future of
Systems Biology and of interdisciplinary research in
biomedicine. A key point emerging from this review is
the characterization and definition of complex biome-
dical system. The notion of complexity, although still
elusive, is giving new tools for the interpretation of
Biology and Medicine. A new interface between Medicine
and Biology is emerging with the contribution of other
sciences such as Physics, Engineering and Mathematics.
As a consequence, new conceptual frameworks are taking
place in biomedicine, and it is becoming clear that it is
no more possible to neglect properties of biomedical
systems arising from small-scale elements like noise,
fluctuations, and global properties, such as integrated
responses at the whole organism level. Within this
scenario, a central role is played by new techniques for
producing and analyzing data that are giving a detailed
picture of the mechanisms governing biological systems,
including humans, that support the concept of obtaining
a personalized medicine. Advanced computer simulation
techniques are having an increasing diffusion in the
biomedical disciplines, and are providing new meth-
odologies for the prediction of their behaviour. These
methodologies range from deterministic to stochastic
algorithms, and are supported by new generations of
hardware that allow huge data storage capability and
computational power. The availability of data storage
and standard communication protocols has fuelled the
appearance of a series of public database and Web
Services, in which it is possible to retrieve a wide class of
biological information. Finally, the conceptual frame-
work of Systems Biology and the definition of Complex
Biomedical System, are giving a new interpretation of
complex pathologies and therapeutic approaches. These
modeling approaches aim to bridge the ‘translational
gap’ between basic and clinical research towards transla-
tional medicine.
Glossary
Bifurcation: a change in the properties of the stable states
of a system described by a mathematical function, e.g.
when the average value of a protein passes from a single
possible value (one stable state) to a high or low
possible value (two stable states).
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Emergent properties: global properties of a system result-
ing from simpler interaction of its elements, rather than
being specifically encoded in it.
False discovery rate: statisticalmethod to control (or at least to
estimate) the expected number of false positives (e.g. cases
called different from the null hypothesis when they are not)
when applying multiple testing (i.e. many statistical tests in
parallel, e.g. while checking for statistically significant
differential expression of thousand of genes).
Fisher’s exact test: a statistical test to check for nonrandom
association between two variables.
Generalized linear model: a generalization of linear
regression between two groups of variables that may
allow for nonlinear relationships.
Maximum Likelihood (ML): The likelihood (L_H) of a
hypothesis (H) is equal to the probability of observing the
data if that hypothesis were correct. The statistical method
of maximum likelihood (ML) chooses amongst hypoth-
eses by selecting the one which maximizes the likelihood;
that is, which renders the data the most plausible.
Markov process: A mathematical model of infrequent
changes of (discrete) states over time, in which future
events occur by chance and depend only on the current
state, and not on the history of how that state was
reached.
Null model: the “null hypothesis” for a statistical test
describes the typical background properties of the model
that should be contradicted in case of significant
deviations from it.
MonteCarlo Markov Chain: Standard MCMC uses a
Markov Chain where a new state is proposed, then
with some probability, the proposed state is accepted or
the previous state is maintained. After a long time of
continuing this process, (under some conditions) states
visited by the Markov Chain approximate a sample from
the posterior density of model parameters given the data.
Plug and play statistics Statistical methods: are plug-and-
play if they require simulation from a dynamic model
but not explicit likelihood ratios.
Phase transition: a macroscopic change in system proper-
ties that result in discountinuous variations in some
observed variables (e.g. the change from liquid to gas as
a function of temperature and pressure changes).
Stochastic fluctuations: changes in time (and space) of an
observed variable (e.g. the expression of a protein) due
to random perturbations (e.g. in the degradation or
synthesis processes).
Thermodynamic approach: a physical approach to the
study of large systems in which the properties of the
single elements (in the limit of the number of elements
going to infinity) are averaged out but macroscopic
features are kept (e.g. the average pressure of a gas
obtained as an average of the single molecular impacts
on the container surface).
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